Multiple sclerosis is a chronic demyelinating disease of the central nervous system. Owing to recent advances in molecular immunology it is clarified that the basis of pathogenesis of this disorder is a mechanism mediated by CD4+cells. Comprehension of this mechanism by clinicians is significant to interpret immunological data in the course of disease for treatment strategies choice.
